Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases.
Thijssen MA, Swinkels DW, Ruers TJ, de Kok JB
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of quantifying cell-free circulating DNA in EDTA plasma versus serum among specimens from patients with liver metastases and previously resected colorectal cancer. Plasma was obtained from K3EDTA tubes while serum was obtained from plain tubes, and both were stored at -80 degrees C until analysis.
Summary of Findings
Serum DNA levels were generally higher than plasma levels and were significantly different between patients and healthy controls (p<0.001), but EDTA plasma levels were not significantly different between cancer patients and healthy controls. For serum, a cut-off value of 35 ng/mL DNA afforded a sensitivity of 42% and a specificity of 93% with regards to prediction of the presence of liver metastasis. The authors state that measured levels of serum DNA were not significantly different between the real time qPCR method and the spectrofluorometric method (PicoGreen), but they do not show data. It was determined that serum DNA levels above the cut-off value were not a reliable predictor of tumor recurrences, but EDTA plasma DNA levels may be predictive of tumor recurrences.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
FrozenDiagnoses
NormalNeoplasticCarcinomaPlatforms
DNAFluorometryDNAReal-time qPCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Liver metastasis of colorectal cancerNo tumor recurrencesNormalTumor recurrencesBiospecimen Aliquots and Components Blood and blood products PlasmaSerumReal-time qPCR Specific Targeted nucleic acid AlbuminReal-time qPCR Specific Technology platform Fluorometry